Literature DB >> 18563595

Tumor dormancy due to failure of angiogenesis: role of the microenvironment.

George N Naumov1, Judah Folkman, Oddbjorn Straume.   

Abstract

Tumor progression is dependent on a number of sequential steps, including initial recruitment of blood vessels (i.e., angiogenic switch). Failure of a microscopic tumor to complete one or more of these early steps may lead to delayed clinical manifestation of the cancer. In this review we summarize some of the clinical and experimental evidence suggesting that microscopic human cancers can remain in an asymptomatic, non-detectable, and occult state for the life of a person or animal. We present three clinical cases where tumors present shortly after an accidental trauma in otherwise healthy individuals. We also review current experimental human tumor dormancy models with special emphasis on the angiogenic switch which closely recapitulates clinically observed delay in tumor recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18563595     DOI: 10.1007/s10585-008-9176-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  64 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  Malignant melanoma in a skin graft: burn scar neoplasm or a transferred melanoma?

Authors:  I E Gamatsi; T A McCulloch; F B Bailie; J R Srinivasan
Journal:  Br J Plast Surg       Date:  2000-06

3.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment.

Authors:  J Folkman; P Cole; S Zimmerman
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

5.  Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice.

Authors:  E G Achilles; A Fernandez; E N Allred; O Kisker; T Udagawa; W D Beecken; E Flynn; J Folkman
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

6.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta.

Authors:  M H Sieweke; N L Thompson; M B Sporn; M J Bissell
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

Review 7.  Surgical trauma and peritoneal recurrence of colorectal carcinoma.

Authors:  S J Oosterling; G J van der Bij; M van Egmond; J R M van der Sijp
Journal:  Eur J Surg Oncol       Date:  2005-02       Impact factor: 4.424

8.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

Authors:  K D Swenerton; S S Legha; T Smith; G N Hortobagyi; E A Gehan; H Y Yap; J U Gutterman; G R Blumenschein
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

9.  Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice.

Authors:  I P Torres Filho; M Leunig; F Yuan; M Intaglietta; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

10.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

Authors:  M Nielsen; J L Thomsen; S Primdahl; U Dyreborg; J A Andersen
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more
  49 in total

1.  Tumour biology: Skin-cancer stem cells outwitted.

Authors:  Salvador Aznar Benitah
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

2.  Multifocal lung cancers--clonality vs field cancerization and does it matter?

Authors:  Adi F Gazdar; John D Minna
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

3.  A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay.

Authors:  Ying Wang; DanQi Chen; MingYu Chen; KaiYuan Ji; DeXuan Ma; LiangFu Zhou
Journal:  J Vis Exp       Date:  2018-04-12       Impact factor: 1.355

4.  The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.

Authors:  Renate M Winkels; Kathleen M Sturgeon; Michael J Kallan; Lorraine T Dean; Zi Zhang; Margaret Evangelisti; Justin C Brown; David B Sarwer; Andrea B Troxel; Crystal Denlinger; Monica Laudermilk; Anna Fornash; Angela DeMichele; Lewis A Chodosh; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2017-07-21       Impact factor: 2.226

Review 5.  Autophagy in cellular metabolism and cancer.

Authors:  Xuejun Jiang; Michael Overholtzer; Craig B Thompson
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

6.  Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.

Authors:  Nathalie Magnus; Delphine Garnier; Brian Meehan; Serge McGraw; Tae Hoon Lee; Maxime Caron; Guillaume Bourque; Chloe Milsom; Nada Jabado; Jacquetta Trasler; Rafal Pawlinski; Nigel Mackman; Janusz Rak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

7.  Modeling progression in radiation-induced lung adenocarcinomas.

Authors:  Hatim Fakir; Werner Hofmann; Rainer K Sachs
Journal:  Radiat Environ Biophys       Date:  2010-01-08       Impact factor: 1.925

Review 8.  Imaging innate immune responses at tumour initiation: new insights from fish and flies.

Authors:  Yi Feng; Paul Martin
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

9.  Tumor cell behaviour modulation by mesenchymal stromal cells.

Authors:  Lucia Kucerova; Miroslava Matuskova; Kristina Hlubinova; Veronika Altanerova; Cestmir Altaner
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

10.  Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Authors:  Michael S Rogers; Katherine Novak; David Zurakowski; Lorna M Cryan; Anna Blois; Eugene Lifshits; Trond H Bø; Anne M Oyan; Elise R Bender; Michael Lampa; Soo-Young Kang; Kamila Naxerova; Karl-Henning Kalland; Oddbjorn Straume; Lars A Akslen; Randolph S Watnick; Judah Folkman; George N Naumov
Journal:  Mol Cancer Res       Date:  2014-02-26       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.